Retractable Tech Q2 net sales $6.0M, operating loss $5.8M; tariff risk on China imports

RETRACTABLE TECHNOLOGIES INC

2024-Q2 EPS reported -$0.46 revenue$13,628,727

Q2 net sales $6.0M, down 25% YoY; operating loss $5.8M vs $5.0M loss.
H1 net sales $13.6M, down 28% YoY; operating loss $8.7M vs $7.8M.
Net loss of $14.2M in Q2 includes $8.3M valuation allowance on deferred tax asset.
Proposed 50% tariffs on China-imported syringes pending; 91% of products sourced from China.
Company evaluating domestic manufacturing shift with ~$1M estimated equipment cost.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.